Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
0.92
-0.01
(-1.57%)
After-Hours: 20:00
Homology Medicines Cash and Short Term Investments (Quarterly): 82.65M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.65M |
| September 30, 2023 | 103.30M |
| June 30, 2023 | 127.07M |
| March 31, 2023 | 150.02M |
| December 31, 2022 | 175.03M |
| September 30, 2022 | 201.07M |
| June 30, 2022 | 225.52M |
| March 31, 2022 | 256.13M |
| December 31, 2021 | 155.87M |
| September 30, 2021 | 187.55M |
| June 30, 2021 | 213.29M |
| March 31, 2021 | 188.65M |
| December 31, 2020 | 217.43M |
| Date | Value |
|---|---|
| September 30, 2020 | 178.00M |
| June 30, 2020 | 206.64M |
| March 31, 2020 | 234.93M |
| December 31, 2019 | 262.39M |
| September 30, 2019 | 269.67M |
| June 30, 2019 | 295.80M |
| March 31, 2019 | 187.97M |
| December 31, 2018 | 214.74M |
| September 30, 2018 | 237.54M |
| June 30, 2018 | 255.51M |
| March 31, 2018 | 116.73M |
| December 31, 2017 | 129.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
82.65M
Minimum
Dec 2023
295.80M
Maximum
Jun 2019
196.37M
Average
201.07M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | 8.095M |
| AgeX Therapeutics Inc (DELISTED) | 0.397M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |